ResearcherUniversity of California, Los AngelesNo recent work listed

Dean Ehrlich

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9606-8429; OpenAlex author ID A5065601835. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper

Papers 1

The Utility of EUS-FNA to Determine Surgical Candidacy in Patients with Pancreatic Cancer after Neoadjuvant Therapy. Co-author DOI 10.1007/s11605-019-04415-6 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Timothy R. Donahue · 1 shared paper, 2020 · strength 0.11
- Paper The Utility of EUS-FNA to Determine Surgical Candidacy in Patients with Pancreatic Cancer after Neoadjuvant Therapy. DOI 10.1007/s11605-019-04415-6 ↗
Rabindra R. Watson · 1 shared paper, 2020 · strength 0.11
- Paper The Utility of EUS-FNA to Determine Surgical Candidacy in Patients with Pancreatic Cancer after Neoadjuvant Therapy. DOI 10.1007/s11605-019-04415-6 ↗
V. Raman Muthusamy · 1 shared paper, 2020 · strength 0.11
- Paper The Utility of EUS-FNA to Determine Surgical Candidacy in Patients with Pancreatic Cancer after Neoadjuvant Therapy. DOI 10.1007/s11605-019-04415-6 ↗
Oscar Joe Hines · 1 shared paper, 2020 · strength 0.11
- Paper The Utility of EUS-FNA to Determine Surgical Candidacy in Patients with Pancreatic Cancer after Neoadjuvant Therapy. DOI 10.1007/s11605-019-04415-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.